About this document
Lung Cancer Genomic Risk Prediction by bhattaraiabhinav480 is a document available to read on EtoBox.
This narrative review discusses the clinical relevance of genomic profiling in non-small cell lung cancer (NSCLC) for staging and prognosis. It highlights the limitations of conventional TNM staging systems and emphasizes the advantages of genomic testing in accurately classifying patients into high and low-risk groups, which can significantly influence treatment decisions and improve survival rates. The review also details the development and validation of a standardized 14-gene assay, DetermaRx, which has
- Author
- bhattaraiabhinav480
- Language
- EN